Clinical Trial Update: A Phase 2a Study to Evaluate ALS-008176 in the Virus Challenge Model [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2a trial evaluating ALS-008176 in a virus challenge model for Respiratory Syncytial Virus infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infections

Drugs mentioned

• ALS-008176

Snippet

Sponsor: Alios Biopharma Inc. | Conditions: Respiratory Syncytial Virus Infections | Phase 2 | Status: COMPLETED